by chodges | Sep 25, 2023 | News
Optibrium Releases Powerful Metabolism Prediction Capability in Next Generation StarDrop Software • Backed by six years’ research, the new StarDrop Metabolism module combines quantum mechanics and machine learning to better predict the metabolic fate of drug...
by chodges | Aug 31, 2023 | News
Optibrium acquires BioPharmics LLC, expanding its 3D drug design and visualisation offering BioPharmics’ Drs Ajay Jain (CEO) and Ann Cleves (Director of Applied Science) join the Optibrium team as Vice Presidents in the newly-created BioPharmics Division Read...
by Katie Strickland | Jun 14, 2023 | News
Augmenting Inspiration with Generative Chemistry Out now in International Biopharmaceutical Industry, Optibrium’s CEO, Dr Matt Segall introduces the concept of augmented intelligence. He explains how to use dynamic learning to generate better compounds for your...
by Katie Strickland | Apr 14, 2023 | News
AI in the Drug Discovery Industry Out now in Innovations in Pharmaceutical Technology, Optibrium’s Global Head of Application Science and President of Optibrium Inc, Dr Tamsin Mansley discusses the past, present and future of AI in drug discovery. She shares her...
by chodges | Apr 4, 2023 | News
Optibrium Appoints Computational Modelling Expert, Dr Hamed Tabatabaei Ghomi as Head of Research Appointment will lead research strategy to apply the latest scientific innovations to Optibrium’s computational and AI drug discovery technologies Hamed brings...
by Marina Chenery | Mar 15, 2023 | News
The collaboration will connect PostEra’s synthesis prediction technology with Optibrium’s comprehensive platform for design, optimisation and data analysis for small molecule discovery CAMBRIDGE, UK and BOSTON, USA, 15 March 2023 – Optibrium, a leading developer of...